RI Stock Analysis: Pernod Ricard S.A. | PA
Beverages - Wineries & Distilleries | PA, France | Market Cap: 16.242m EUR | 12M Return: -32.7% | FR0000120693 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 39.8M
EPS Trend: -49.6%
Qual. Beats: 0
Rev. Trend: -82.8%
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pernod Ricard SA is a France-based global producer of wines and spirits, headquartered in Paris and listed on the Euronext Paris exchange under the ticker RI. The company was founded in 1805 and operates as a major large-cap player in the Consumer Staples sector, specifically within the Distillers & Vintners sub-industry.
Its portfolio spans a wide range of alcoholic categories, including whiskey, vodka, gin, rum, liqueurs and bitters, champagne, tequila and mezcal, and aperitifs, marketed under well-known brands such as Absolut, Jameson, Chivas, Ballantines, Malibu, Kahlúa, Jacobs Creek, Mumm, and Martell, among many others. The company has also expanded into non-alcoholic alternatives, offering zero-proof versions under brands such as Beefeater 0%, Ceders, and Campo Viejo Sparkling 0%.
As a major participant in the global premium spirits industry, Pernod Ricard relies on a multi-brand portfolio model that targets diverse geographies and consumer segments, balancing mature markets with high-growth regions. Its long operating history and extensive brand library reflect a business model focused on premiumisation, distribution scale, and category diversification across both on-trade and off-trade channels.
- China cognac demand slump pressures Martell sales growth
- Travel retail and US premium spirits drive price-mix gains
- Strong euro erodes reported revenue and operating profit
| Net Income: 3.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 3.59 > 1.0 |
| NWC/Revenue: 36.65% < 20% (prev 27.98%; Δ 8.67% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.52b > Net Income 3.17b |
| Net Debt (11.6b) to EBITDA (6.15b): 1.89 < 3 |
| Current Ratio: 2.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (252.1m) vs 12m ago -0.51% < -2% |
| Gross Margin: 59.81% > 18% (prev 59.92%; Δ -0.11% > 0.5%) |
| Asset Turnover: 52.46% > 50% (prev 59.64%; Δ -7.19% > 0%) |
| Interest Coverage Ratio: 5.55 > 6 (EBIT TTM 5.54b / Interest Expense TTM 997.5m) |
| A: 0.20 (Total Current Assets 13.0b - Total Current Liabilities 5.60b) / Total Assets 37.7b |
| B: 0.03 (Retained Earnings 975.0m / Total Assets 37.7b) |
| C: 0.14 (EBIT TTM 5.54b / Avg Total Assets 38.7b) |
| D: 0.73 (Book Value of Equity 15.5b / Total Liabilities 21.1b) |
| Altman-Z'' = 3.11 = A |
| DSRI: 1.11 (Receivables 2.10b/2.20b, Revenue 20.3b/23.7b) |
| GMI: 1.00 (GM 59.92% / 59.81%) |
| AQI: 0.98 (AQ_t 0.54 / AQ_t-1 0.55) |
| SGI: 0.86 (Revenue 20.3b / 23.7b) |
| TATA: -0.01 (NI 3.17b - CFO 3.52b) / TA 37.7b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of August 29, 2026, the stock is trading at EUR 63.20 with a total of 921,624 shares traded. Over the past week, the price has changed by -7.63%, over one month by -6.76%, over three months by +1.79% and over the past year by -32.74%.
Current recommended Stop Loss: 60.30 (which is 4.6% or 1.6 ATR below the current price).
Pernod Ricard S.A. has no consensus analysts rating.
P/E Trailing = 11.5179
P/E Forward = 10.6496
P/S = 1.6184
P/B = 1.1
P/EG = 2.0433
Revenue TTM = 20.3b EUR
EBIT TTM = 5.54b EUR
EBITDA TTM = 6.15b EUR
Long Term Debt = 11.6b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.68b EUR (from shortTermDebt, last quarter)
Debt = 14.0b EUR (from shortLongTermDebtTotal, last quarter) + Leases 419.0m
Net Debt = 11.6b EUR (calculated: Debt 14.0b - CCE 2.40b)
Enterprise Value = 27.9b EUR (16.2b + Debt 14.0b - CCE 2.40b)
Interest Coverage Ratio = 5.55 (Ebit TTM 5.54b / Interest Expense TTM 997.5m)
EV/FCF = 12.36x (Enterprise Value 27.9b / FCF TTM 2.25b)
FCF Yield = 8.09% (FCF TTM 2.25b / Enterprise Value 27.9b)
FCF Margin = 11.10% (FCF TTM 2.25b / Revenue TTM 20.3b)
Net Margin = 15.62% (Net Income TTM 3.17b / Revenue TTM 20.3b)
Gross Margin = 59.81% ((Revenue TTM 20.3b - Cost of Revenue TTM 8.17b) / Revenue TTM)
Gross Margin QoQ = 59.28% (prev 57.35%)
Tobins Q-Ratio = 0.74 (Enterprise Value 27.9b / Total Assets 37.7b)
Interest Expense / Debt = 7.11% (Interest Expense 997.5m / Debt 14.0b)
Taxrate = 24.41% (1.05b / 4.32b)
NOPAT = 4.18b (EBIT 5.54b * (1 - 24.41%))
Current Ratio = 2.33 (Total Current Assets 13.0b / Total Current Liabilities 5.60b)
Debt / Equity = 0.91 (Debt 14.0b / totalStockholderEquity, last quarter 15.5b)
Debt / EBITDA = 1.89 (Net Debt 11.6b / EBITDA 6.15b)
Debt / FCF = 5.15 (Net Debt 11.6b / FCF TTM 2.25b)
Total Stockholder Equity = 15.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.19% (Net Income 3.17b / Total Assets 37.7b)
RoE = 20.16% (Net Income TTM 3.17b / Total Stockholder Equity 15.7b)
RoCE = 20.25% (EBIT 5.54b / Capital Employed (Equity 15.7b + L.T.Debt 11.6b))
RoIC = 12.78% (NOPAT 4.18b / Invested Capital 32.7b)
WACC = 5.39% (E(16.2b)/V(30.3b) * Re(5.41%) + D(14.0b)/V(30.3b) * Rd(7.11%) * (1-Tc(0.24)))
Discount Rate = 5.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -39.98 | Cagr: -1.62%
[DCF] Terminal Value 77.97% ; FCFF base≈1.73b ; Y1≈1.99b ; Y5≈2.93b
[DCF] Fair Price = 128.7 (EV 44.0b - Net Debt 11.6b = Equity 32.4b / Shares 251.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -49.59 | EPS CAGR: -25.22% | SUE: 0.0 | # QB: 0
Revenue Correlation: -82.83 | Revenue CAGR: -8.79% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=5.74 | Chg30d=-0.02% | Revisions=-7% | GrowthEPS=-20.9% | GrowthRev=-13.5%
EPS next Year (2027-06-30): EPS=5.85 | Chg30d=+0.00% | Revisions=-13% | GrowthEPS=+0.1% | GrowthRev=+0.7%
[Analyst] Revisions Ratio: -12% (up=10, down=13)